Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 79063

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 05, 2018
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
PharMEDium Services, LLC

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

15 units Oxytocin added to 0.9% Sodium Chloride Injection, 250 mL Viaflex Bag, Rx only, PharMEDium Serivces, LLC

D-0422-2018
Recall number
D-0422-2018
Initiated
February 05, 2018
Classification
Class II
Status
Terminated
Recalling firm
PharMEDium Services, LLC
Quantity
24 Viaflex Bag

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
out of specification
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

Code information

Lot #: 180040003D, Exp 3/18/18

Distribution pattern

Product was distributed to SC, FL, NY, NY,WA

drug · product 2 of 3

0.2% Ropivacaine HCI (Preservative Free) in 0.9 Sodium Chloride, Epidural, 250 mL Yellow Cassette, Rx only, PharMEDium Serivces, LLC

D-0423-2018
Recall number
D-0423-2018
Initiated
February 05, 2018
Classification
Class II
Status
Terminated
Recalling firm
PharMEDium Services, LLC
Quantity
21 Cassettes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
out of specification
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

Code information

Lot #: 180030029D, Exp 2/18/18

Distribution pattern

Product was distributed to SC, FL, NY, NY,WA

drug · product 3 of 3

100 mcg / mL Phenylephrine HCl (Preservative Free) Injection, 10 mL syringe, Rx only, PharMEDium Serivces, LLC

D-0424-2018
Recall number
D-0424-2018
Initiated
February 05, 2018
Classification
Class II
Status
Terminated
Recalling firm
PharMEDium Services, LLC
Quantity
500 syringes

App-derived interpretation

Potency or specification failure reason.potency_specification_failure · v1.0.0
out of specification
Sterility assurance reason.sterility_assurance · v1.0.0
Lack of assurance of sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of assurance of sterility: Three lots were released where there was a failure to follow proper testing and investigation procedures. Product may be out of specification (OOS) for endotoxin.

Code information

Lot #: 180080063D, Exp 4/9/18

Distribution pattern

Product was distributed to SC, FL, NY, NY,WA